| David G Bryan, MD | |
|
312 Grammont St, Ste 300, Monroe, LA 71201-7403 | |
| (318) 388-4030 | |
| (318) 324-3334 |
| Full Name | David G Bryan |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 312 Grammont St, Monroe, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396748604 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 016816 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David G Bryan, MD 312 Grammont St, Ste 300, Monroe, LA 71201-7403 Ph: (318) 388-4030 | David G Bryan, MD 312 Grammont St, Ste 300, Monroe, LA 71201-7403 Ph: (318) 388-4030 |
News Archive
The need to enhance healthcare delivery is driving the market for IT professional services in Europe. Adoption levels are, however, being hampered by budget cuts and end user reluctance to invest in such services. These trends have triggered several changes in the market, including consolidation and the adoption of inorganic growth models.
Heavy drinkers develop behavioral tolerance to alcohol over time on some fine motor tasks, but not on more complex tasks, according to a study led by a Veterans Affairs San Diego Healthcare System researcher. While heavy drinkers showed less impairment than light drinkers on a rote fine motor test over time, they did not perform better on a test involving more short-term memory, motor speed, and more complex cognitive processing.
More than half of the world's population faces a looming threat to the quality and availability of their drinking water because climate change and urbanization are expected to cause an increase in groundwater organic carbon, a new UNSW study has found.
Scientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to a Phase I trial reported today in Clinical Cancer Research.
Cubist Pharmaceuticals, Inc. today announced that its currently-marketed antibiotic, CUBICIN (daptomycin for injection), has been approved by the U.S. Food & Drug Administration (FDA) for once-a-day dosing as a 2-minute intravenous (IV) injection.
› Verified 7 days ago
Dr. Eddye Blossom Ii, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4864 Jackson St, Monroe, LA 71202 Phone: 318-330-7626 Fax: 318-330-7648 | |
Amber M Shemwell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 312 Grammont St Ste 300, Monroe, LA 71201 Phone: 318-388-4030 Fax: 318-325-8437 | |
Dr. Laura Rush Petty, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 312 Grammont St Ste 300, Monroe, LA 71201 Phone: 318-388-4030 | |
Dr. Laurie Renee Lebleu-vaszily, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 312 Grammont St, Ste 300, Monroe, LA 71201 Phone: 318-398-2373 Fax: 318-998-3999 | |
Jason B Wilson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 312 Grammont St, Ste 300, Monroe, LA 71201 Phone: 318-388-4030 Fax: 318-325-8437 | |
Won S Lee, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 312 Grammont St, Ste 300, Monroe, LA 71201 Phone: 318-388-4030 Fax: 318-324-3334 | |
Dr. Janice Rose Pharr, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4864 Jackson St, Monroe, LA 71202 Phone: 318-330-7626 Fax: 318-330-7648 |